ID   HDLM-3
AC   CVCL_M697
SY   HDLM3
DR   Wikidata; Q54882177
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3713248;
RX   PubMed=29533902;
CC   Population: Caucasian.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M693 ! HDLM-1
OI   CVCL_0009 ! HDLM-2
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=3713248; DOI=10.1016/0145-2126(86)90084-6;
RA   Drexler H.G., Gaedicke G., Lok M.-S., Diehl V., Minowada J.;
RT   "Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of
RT   morphology, immunological and isoenzyme profiles.";
RL   Leuk. Res. 10:487-500(1986).
//
RX   PubMed=29533902; DOI=10.1515/hsz-2017-0321;
RA   Drexler H.G., Pommerenke C., Eberth S., Nagel S.;
RT   "Hodgkin lymphoma cell lines: to separate the wheat from the chaff.";
RL   Biol. Chem. 399:511-523(2018).
//